Medco's New Idea: PGx Program for Generics to Dispense 'Smarter' Treatments and Increase Savings | GenomeWeb

By Turna Ray

"Genetics for Generics" is Medco's newest idea for optimizing savings for payors by dispensing off-patent drugs with the aid of genetic tests.

"We have a strategy that we're calling Genetics for Generics," Medco's Chief Medical Officer Robert Epstein told Pharmacogenomics Reporter this week. "It's kind of a Medco idea, which is that if we can make generic drugs work better with genetics, then we are helping the system afford innovative products that address true unmet need."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.